Related Experiment Videos

Role of ICAM-1 (CD54) in the development of murine cerebral malaria

N Favre1, C Da Laperousaz, B Ryffel

  • 1Department of Medical Parasitology, Swiss Tropical Institute, Postfach, CH-4002 Basel, Switzerland.

Microbes and Infection
|January 5, 2000
PubMed

Insights

Intercellular Adhesion Molecule-1 (ICAM-1) deficiency protects mice from lethal cerebral malaria by reducing parasite sequestration and macrophage trapping, despite similar immune responses. This highlights ICAM-1

Area of Science:

  • Immunology
  • Pathology
  • Parasitology

Background:

  • Plasmodium berghei ANKA (PbA) infection causes lethal cerebral malaria in susceptible mice.
  • Cerebral malaria pathogenesis involves parasite-induced immune responses, including TNF production and increased endothelial adhesion molecule expression.

Purpose of the Study:

  • To investigate the role of the adhesion molecule ICAM-1 (CD54) in the development of cerebral malaria.
  • To compare PbA infection outcomes in wild-type and ICAM-1-deficient mice.

Main Methods:

  • Infection of wild-type (+/+) and ICAM-1-deficient (-/-) mice with PbA.
  • Monitoring of survival, parasitemia, serum TNF and IFN-gamma levels.
  • Analysis of blood-brain barrier integrity, thrombocytopenia, and immune cell/parasitized RBC sequestration in various organs.

Main Results:

  • ICAM-1-deficient mice survived significantly longer than wild-type mice.
  • Parasitemia and IFN-gamma levels were similar between groups; serum TNF was higher in wild-type mice.
  • Reduced breakdown of the blood-brain barrier, less severe thrombocytopenia, and decreased sequestration of macrophages and parasitized red blood cells in ICAM-1-deficient mice.

Conclusions:

  • ICAM-1 plays a critical role in PbA-induced cerebral malaria pathogenesis.
  • Absence of ICAM-1 protects mice by mitigating vascular sequestration and associated pathologies.
  • Targeting ICAM-1 may offer a therapeutic strategy against cerebral malaria.

Related Concept Videos